惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

博客园 - 叶小钗
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
Microsoft Security Blog
Microsoft Security Blog
罗磊的独立博客
大猫的无限游戏
大猫的无限游戏
美团技术团队
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
aimingoo的专栏
aimingoo的专栏
腾讯CDC
WordPress大学
WordPress大学
Apple Machine Learning Research
Apple Machine Learning Research
F
Fortinet All Blogs
G
Google Developers Blog
MongoDB | Blog
MongoDB | Blog
Microsoft Azure Blog
Microsoft Azure Blog
小众软件
小众软件
Engineering at Meta
Engineering at Meta
博客园_首页
B
Blog RSS Feed
D
Docker
M
MIT News - Artificial intelligence
爱范儿
爱范儿
I
InfoQ

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Arvinas, Inc. (ARVN) Q1 2026 Earnings Call Transcript
2026-05-13 · via All Articles on Seeking Alpha

Q1: 2026-05-11 Earnings Summary

EPS of -$0.90 beats by $0.06

 | 

Revenue of

$15.60M

(-91.74% Y/Y)

misses by $1.01M

Arvinas, Inc. (ARVN) Q1 2026 Earnings Call May 12, 2026 8:00 AM EDT

Company Participants

Jeff Boyle - Vice President of Investor Relations
Randy Teel - CEO, President & Director
Noah Berkowitz - Chief Medical Officer
Angela Cacace - Chief Scientific Officer
Andrew Saik - CFO & Treasurer

Conference Call Participants

Sudan Loganathan - Stephens Inc., Research Division
Michael Schmidt - Guggenheim Securities, LLC, Research Division
Ananda Ghosh - H.C. Wainwright & Co, LLC, Research Division
Jonathan Miller - Evercore ISI Institutional Equities, Research Division
Kyuwon Choi - Goldman Sachs Group, Inc., Research Division
Jeet Mukherjee - BTIG, LLC, Research Division
Manoj Eradath - Jefferies LLC, Research Division
Daniel Bronder - Cantor Fitzgerald & Co., Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Arvinas First Quarter 2026 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Jeff Boyle, Head of Investor Relations. Please go ahead.

Jeff Boyle
Vice President of Investor Relations

Good morning, everyone, and thank you for joining us. Earlier today, we issued a press release with our first quarter 2026 financial results, which is available in the Investor and Media section of our website at arvinas.com. Joining us on the call today, we have Randy Teel, our President and CEO; Noah Berkowitz, our Chief Medical Officer; Angela Cacase, our Chief Scientific Officer; and Andrew Saik, our Chief Financial Officer.

Before we begin, I'll remind you that today's discussion contains forward-looking statements that involve risks, uncertainties and assumptions. These risks and uncertainties are outlined in today's press release and in the company's recent filings with the Securities and Exchange Commission, which I urge you to read. Our actual results may differ materially from what is discussed on today's call. A replay of the call as well as today's